What SNP Therapeutics does

SNP Therapeutics, LLC is a privately held precision nutrition company headquartered at the North Carolina Research Campus in Kannapolis that develops gene-guided genetic tests and companion nutritional supplements. Its core technology is the SNPhub™ platform — a HIPAA-compliant machine-learning and AI system that processes clusters of SNPs across interdependent metabolic pathways, rather than single polymorphisms, to identify genetic signatures associated with metabolic inefficiencies and to predict responsiveness to nutritional intervention.

The company's commercial portfolio spans four indication areas: The Genate Test (prenatal precision nutrition, evaluating 317 SNPs across five nutrient pathways in one-carbon and fatty acid metabolism), a U.S.-patented Male Infertility / ATP-Sperm Function Test, a Muscle Wasting / Rhabdomyolysis Test, and a NAFLD Test reported at 92% predictive accuracy. Test results are coupled with branded supplements, including the Genate Essential Prenatal Multivitamin, fulfilled through an integration with the Fullscript integrative medicine platform. The company sells direct-to-consumer via genate.com, through healthcare practitioners via the SNP Portal, and through white-label/co-brand partnerships with prenatal nutrition brands backed by affiliate commissions.

SNP Therapeutics was founded by Steven H. Zeisel, MD, PhD (UNC Kenan Distinguished Professor, NIH-funded, 350+ publications on choline and nutrition), with pharmaceutical-industry commercial leadership under CEO Jon Kleu (former Pfizer/Upjohn, Daiichi Sankyo, Syneos Health). Scientific credibility is reinforced by an advisory bench spanning ex-Quest Diagnostics clinical genomics leadership and UNC Nutrition Research Institute faculty. There are no disclosed funding rounds or revenue figures in the available data, and the company is currently soliciting investment through a dedicated outreach channel.

Name

SNP Therapeutics

Legal name

SNP Therapeutics, LLC

Website

https://snptherapeutics.com

Company type

Private

Operating status

Operating

Headcount range

1–10 employees

Short description

SNP Therapeutics is a privately held precision nutrition company that sells gene-guided genetic tests (prenatal, NAFLD, muscle wasting, male infertility) and companion supplements powered by its proprietary SNPhub™ multi-SNP AI platform, serving consumers, healthcare practitioners, and prenatal nutrition brand partners.

Ownership category

akta.pro rank

Product category

Precision Nutrition

NAICS

Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215), Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Services-Medical Laboratories (8071), In Vitro & In Vivo Diagnostic Substances (2835)

akta.pro primary industry

Genetic & Prenatal Testing Laboratories (HLAFAMAH)

akta.pro secondary industries

Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics) (HLAAALAD), Prenatal, Newborn & Reproductive Diagnostics (NIPT, IVF/PGT, newborn screening) (HLAAALAJ)

Keywords

• Precision nutrition genetics
• Prenatal genetic testing
• Nutrigenomics diagnostics
• Gene-guided supplements
• Metabolic SNP analysis

Headquarters

HQ city

Kannapolis

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations, Supply Chain

Revenue model

1. Genetic Testing Products: SNP Therapeutics generates revenue through the sale of proprietary genetic tests including the Genate Prenatal Test, NAFLD genetic test, muscle wasting test, and male infertility (ATP-sperm function) test. Tests are sold directly to consumers via genate.com and through partner channels (healthcare practitioners, nutrition brands). The company also earns affiliate commissions for tests sold through partner channels.
2. Nutritional Formulations and Supplements: Sale of patented nutritional formulations tailored to each patient's genetic signature. Genate Essential Prenatal Multivitamin and other nutrition supplements are sold as customized solutions. Integrated with Fullscript platform for supplement fulfillment and delivery directly to patients.
3. Partner Affiliate Referrals: Attractive affiliate commission for every genetic test sold through partner channels, as well as direct referrals to partner prenatal nutrition brands. SNP partners receive both direct test sales revenue share and referrals to their branded nutrition products.

Go-to-market motion4 records

Distribution channels4 records

Marketing channels6 records

Core offering

SNP Therapeutics develops and sells proprietary genetic tests and personalized nutritional supplements for precision nutrition. Its SNPhub™ machine learning platform analyzes clusters of SNPs across interdependent metabolic pathways to generate individualized genetic reports and treatment recommendations for prenatal nutrition (Genate Test), male factor infertility (ATP-sperm function), muscle wasting/rhabdomyolysis, and NAFLD. Tests are sold directly to consumers, through healthcare practitioners, and via co-branded partnerships with prenatal nutrition brands.

Product overview

SNP Therapeutics is a precision nutrition company that offers a portfolio of gene-guided genetic tests powered by its proprietary SNPhub™ machine learning platform. The core product suite includes The Genate Test (prenatal precision nutrition), Male Infertility Genetic Test, Muscle Wasting Genetic Test, and NAFLD Genetic Test. All tests evaluate multiple SNPs across interdependent metabolic pathways using AI algorithms to identify genetic signatures and predict responsiveness to nutritional interventions. The platform is complemented by Genate Nutrition supplements (powered by Fullscript integration) that provide personalized nutritional formulations based on genetic test results.

Differentiator

Problem solved

Functional benefit

Brands

• Genate: Prenatal precision nutrition test and supplement brand including The Genate Test (prenatal genetic test) and Genate Essential Prenatal Multivitamin
• SNPhub

Products and services

• The Genate Test The first comprehensive prenatal precision nutrition test focused on one-carbon and fatty acid metabolism — both essential for optimal brain and cognitive development. The Genate Test evaluates 317 functional and complementary SNPs across 5 nutrient pathways, supports fetal brain development, and is targeted at pregnant or pre-conception women. Sold directly to consumers via genate.com and through healthcare practitioners and partner brands.
• Male Infertility / ATP-Sperm Function Genetic Test U.S. patented genetic test, algorithm, and nutrition treatment for men with sperm function difficulties. Identifies the sub-population of men at high risk for ATP-sperm dysfunction due to variant genes in metabolic pathways associated with spermatic ATP concentrations, and pairs identification with a patented nutritional formulation. Targeted at men with sperm function challenges and couples seeking conception prior to IVF.
• Muscle Wasting / Rhabdomyolysis Genetic Test Genetic test and algorithm identifying the subset of the population unable to maintain muscle mass due to SNPs that prevent proper metabolism of one-carbon nutrients. Multi-gene examination within interrelated metabolic pathways supports identification of patients at risk for sarcopenia and rhabdomyolysis. Targeted at athletes, the elderly, and military populations.
• NAFLD Genetic Test Genetic test predicting responsiveness to nutritional intervention for Nonalcoholic Fatty Liver Disease (NAFLD). Identifies a unique gene signature within a sub-population that cannot efficiently export fat from their liver, with 92% accuracy in predicting NAFLD development. Targeted at individuals at risk of or diagnosed with NAFLD.
• Genate Nutrition Supplements Customized prenatal nutritional supplements including the Genate Essential Prenatal Multivitamin and other formulations tailored to a patient's genetic nutritional needs based on The Genate Test results. Fulfilled and delivered directly to patients through the Fullscript integrative medicine platform integration.

Quantifiable outcome

• 92% accuracy in predicting NAFLD development in individuals with specific genetic polymorphisms
• +5 more outcomes

Segments6 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

AI capability2 records

Feature6 records

Partnerships

One partnership is on record.

• FullscriptcoreTechnology or IntegrationSNP Therapeutics is integrated with Fullscript, a free integrative medicine platform offering personalized treatment planning, active wellness support, and access to supplements and wellness products. SNP Therapeutics practitioners can provide supplement recommendations delivered directly to patient doors without leaving the SNP Therapeutics platform.

Scale indicators10 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Myriad Genetics: Myriad is a large established genetic testing company with broad hereditary disease and oncology offerings. While not focused on nutrition, it represents the established clinical genetic testing model that SNP Therapeutics' tests could eventually compete against in physician adoption.
• Color Genomics: Color offers clinical-grade genetic testing across multiple categories including hereditary cancer, heart health, and medication response. While not nutrition-focused, it competes for the same healthcare practitioner channel and represents a more scalable clinical genetic testing model.
• 23andMe: 23andMe is the largest DTC genetic testing company with health-focused panels that include some nutrition and wellness traits. While far broader in scope, it competes for the same health-conscious consumer seeking genetic insights and benefits from massive scale and brand recognition.
• Natera: Natera is a leading reproductive and oncology genetic testing company whose Vistara prenatal single-gene test addresses similar physician channels. It represents a much larger incumbent in the prenatal genetic testing space where SNP Therapeutics' Genate operates.
• Sema4: Sema4 (now GeneDx) provides women's health and reproductive genetic testing including carrier screening. It overlaps with SNP Therapeutics' prenatal channel and represents scaled competition in the OB/GYN ordering market.

Direct peers

• Viome: Viome offers personalized nutrition recommendations based on microbiome and genetic analysis, with supplements shipped DTC. Both companies combine genetic/molecular testing with proprietary supplement formulations in a similar precision nutrition bundle.
• Nutrigenomix: Nutrigenomix is a direct competitor offering genetic tests for personalized nutrition recommendations, including prenatal nutrition panels. Both companies serve healthcare practitioners and consumers with SNP-based nutrition guidance using similar B2B/B2C GTM approaches.

Emerging players

• Orig3n: Orig3n provides direct-to-consumer genetic tests focused on health, wellness, and nutrition traits. It overlaps with SNP Therapeutics' consumer-facing nutrigenomics positioning though with broader and less clinically-validated panels.
• Thorne: Thorne is a premium supplement brand with healthcare practitioner distribution that has begun integrating genetic and biomarker testing. It represents a complementary precision nutrition brand that could either partner with or compete against SNP Therapeutics in personalized supplement delivery.

Others

• Fullscript: Fullscript is SNP Therapeutics' integrative medicine platform partner for supplement fulfillment. While not a competitor, it represents the broader ecosystem of practitioner-focused supplement distribution platforms where genetic testing services are increasingly bundled.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/snptherapeutics
• LinkedInlinkedin.com/company/snp-therapeutics

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles13 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about SNP Therapeutics